Implementing selective treatment of non-severe clinical mastitis in Flanders, Belgium via an “on-practice” approach

Antibiotic resistance in human- and animal-associated pathogens is a well-known and emerging problem (Singer et al., 2003; Dong et al., 2021). Although the contribution of the dairy sector to the antibiotic resistance problem in humans is quite low, we should act more responsibly when it comes to using antibiotics (Tel et al., 2012; Nobrega et al., 2018).

Antibiotics on dairy herds are typically used related to udder health and a reduction in the use is possible by maximizing prevention and by applying selective dry cow therapy. Implementing selective treatment of non-severe clinical mastitis is a valuable third option.

Recently, M-teamUGent at Ghent University, Belgium started a field trial as part of a larger Flanders Innovation and Entrepreneurship-funded project (HBC.2020.3192) together with Animal Health Service Flanders, Hooibeekhoeve and the Flanders Research Institute for Agriculture, Fisheries and Food. The project aims at transferring relevant scientific findings towards dairy practice through communication and training.

Read More